Biblio

Found 60 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is Daisuke Aoki  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
80 and over Antineoplastic Combined Chemotherapy Protocols/*administration & dosage Carboplatin/administration & dosage Female Humans Middle Aged Ovarian Neoplasms/*drug therapy/pathology/surgery Paclitaxel/administration & dosage Survival Analysis
N. Katsumata, Yasuda, M., Takahashi, F., Isonishi, S., Jobo, T., Aoki, D., Tsuda, H., Sugiyama, T., Kodama, S., Kimura, E., Ochiai, K., Noda, K., and Group, J. Gynecologi, Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial, Lancet, vol. 374, pp. 1331-8, 2009.
Adjuvant Endometrial Neoplasms/*drug therapy/pathology/*surgery Female Humans Japan Neoplasm Staging Paclitaxel/administration & dosage *Physician's Practice Patterns Postoperative Care/methods
Y. Watanabe, Kitagawa, R., Aoki, D., Takeuchi, S., Sagae, S., Sakuragi, N., Yaegashi, N., and Group, D. Committee, Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese Gynecologic Oncology Group, Gynecol Oncol, vol. 115, pp. 456-9, 2009.
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carboplatin/administration & dosage Disease-Free Survival Fallopian Tube Neoplasms/*drug therapy/mortality/pathology Female Humans Neoplasm Staging Neoplasms
N. Katsumata, Yasuda, M., Isonishi, S., Takahashi, F., Michimae, H., Kimura, E., Aoki, D., Jobo, T., Kodama, S., Terauchi, F., Sugiyama, T., Ochiai, K., and Group, J. Gynecologi, Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial, Lancet Oncol, vol. 14, pp. 1020-6, 2013.
Antineoplastic Combined Chemotherapy Protocols/therapeutic use Carboplatin/administration & dosage Chemotherapy
Y. Watanabe, Kitagawa, R., Aoki, D., Takeuchi, S., Sagae, S., Sakuragi, N., Yaegashi, N., and Group, D. Committee, Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese Gynecologic Oncology Group, Gynecol Oncol, vol. 115, pp. 456-9, 2009.
Clear Cell/*drug therapy Adult Aged Antineoplastic Agents/*therapeutic use Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Camptothecin/administration & dosage/analogs & derivatives Carboplatin/administration & dosage Cisplatin/administra
S. Takakura, Takano, M., Takahashi, F., Saito, T., Aoki, D., Inaba, N., Noda, K., Sugiyama, T., Ochiai, K., and Group, J. Gynecologi, Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study, Int J Gynecol Cancer, vol. 20, pp. 240-7, 2010.
Clinical Trials as Topic Female *Genital Neoplasms
S. Sagae, Aoki, D., Susumu, N., Okamoto, A., Aotani, E., Takeuchi, M., and Mandai, M., [Current movement in global clinical trials–discussion at Gynecologic Cancer Intergroup (GCIG)], Nihon Rinsho, vol. 70 Suppl 4, pp. 59-66, 2012.

Pages